nanotechnology in medicine СЕМ -ТЕСН apparatus – an ... · and like homeopathy, brr mode...
TRANSCRIPT
1
NANOTECHNOLOGY IN MEDICINE
СЕМ®-ТЕСН Apparatus – An Effective Supplement to Traditional Thera-pies:
• Whenthereisariskofpolypharmacyinapatientwithseveralconditions.• Forpatientswithchronicconditions.• Whenapatientisexperiencingcomplicationsandsideeffectsfrompharmacological
treatment.• Whentraditionaltreatmentmethodsdonotyieldeffectiveresults.• Forpatientswithdrugresistanceorintolerance.• Whentherearecontraindicationsagainstothertreatmentmethods.
Advantages of using the СЕМ®-ТЕСН Apparatus:
1. Severalmethodsfortreatingawiderangeofdiseases:• EHFtherapy—extremelyhighfrequencyelectromagneticradiationinsingle-frequen-
cymodeorusingselectednoise-likemode;• IRtherapy—infraredradiation;• BRRtherapy—usingbackgroundresonanceradiation.2. Compact,withindependentpowersupply.3. Correspondingtophysiotherapeuticmethodswhichareconnectedwithuselowinten-
sivesourcesofelectromagneticradiation.4. Complementsothertreatmentmethods.
СЕМ®-therapy — therapy with the СЕМ®-ТЕСН apparatus uses EHF therapy followed by treatment in BRR mode. СЕМ®-therapy:
• Reducesanytypeofpain,reducesinflammationatpathologicalsites.• Cutsthedurationofstandardtreatmentforawidearrayofdiseases.• Expandsoptionsforout-patientandat-homerehabilitation.• Offerstoolsforprimaryandsecondaryprevention.• Increasetheeffectivenessofpharmacologicaltherapywhilereducingandinsomecases
eveneliminatingdosages.ClinicalresearchesconfirmgoodshippingEHF-therapies,absenceofcomplicationsand
by-effects,includingatlongsupervisionoverthetreatedpatientsuptotwoyearsaftertreat-ment.
2
NANOTECHNOLOGY IN MEDICINEExtremely high frequencies (EHF) are in therangeof30—300GHz(withwave-
lengthsof10-1mm).EHFcausesfrequencyresonanceinbiologicalorganisms,andtherapeuticefficacyisobservedatradiationlevelsmuchlowerthanthosefoundinoth-erranges.Thiscanbeexplainedbyalackofadaptationtothisspecifictypeofcosmic
radiation, which is trapped by the atmosphere, as well as by the signal’s close resemblancetothebody’sownelectromagneticwaves.
What sets the СЕМ®-ТЕСН apparatus apartfromotherEHFtherapiesisitsoptionofus-ingBRRmode,whichoperatesaccording to thehomeopathicprincipleof likecuring like.Andlikehomeopathy,BRRmodeisnon-intensive.
Background resonance radiation therapy (BRR) isbasedontheuseofmemorymaterialsthatcreateaspectralcopyoftheradiationemittedbythecellsoflivingorganismsintheEHFrangeandcauseitsautomaticretransmission(Gunndiode).Byinfluencingthefrequencyresonancesofcellstructures,pathologicalprocessescanbeweakenedorblockedentirely,atthesametimeamplifyingphysiologicaloscillationsandrestoringdynamicequilibriuminthepatient’sbody.
Whenappliedtohumanskin,EHFradiationpenetratestoadepthof300—500microns,meaningthat it isalmostentirelyabsorbedbytheepidermisandupperlayersofthedermis.
Withitsdirecteffectstargetedatnervereceptors,thecapillarybed,skindepositoriesofleuko-cytesandcellsofthediffuseneuro-endocrinesystem,the therapeutic action of EHF therapy is directed at:
• thenervoussystem;• theimmunesystemandphagocytes;• bloodaggregatestateregulators(coagulatoryandanti-coagulatorymechanisms);• humoralregulation.SoEHFtherapyiseffectiveintreatingawidearrayofdiseases.
СЕМ®— Controlled Energy Material Technology
3
NANOTECHNOLOGY IN MEDICINE
Methods for using the СЕМ®-ТЕСН apparatus:
1) EHFandIRradiationcanbeappliedtoapathologicalsite,reflexogeniczonesand/orbioactivepointsonthebodyusinginterchangeableemitterswithvariousmodu-latingfrequenciesandradiationspectrum(theapparatusisprogrammedtoworkoneachzoneorpointfor10minutes);
2) BRRmode:Whentheemitterisappliedtothepathologicalsite,itsdipole-activemodeisadjustedoverthecourseofoneminute,afterwhichitswitchestoautomaticretransmissionatthesamezone(atthispointtheemitterisfixedtothepatient).Thenumberoftimesthispro-cessesisrepeateddependsontheacutenessofthediseaseprocess,fromhourlyapplicationsforacutecasestoonce-dailyapplicationsforchronicconditions.
Aroundoftherapyusuallyinvolvesdailyproceduresperformedfor5to10days.
Key indications for using EHF therapy:
• Initialpresentationofacuteviralrespiratoryinfections.• Painsyndromeatanylocation.• Jointandspineconditions.• Wounds,hematomas,burns.• Allergiesandskinconditions.• Cardiovasculardisease.• Diseaseofreproductionsystem.
EHF therapy should NOT be used in the following instances:
• Forpatientswithoutapositivediagnosis.• Forpatientswithindividualintolerancetothetherapy.• Forpregnantpatients.• For patients with implant devices with independent power supply, such as artificial
pacemakers.EHFtherapyhasamildsedativeeffectthatmaycausedrowsinessandreducedattention
inpatientswithheightenedsensitivitytoEHFradiation.Insuchcases,itisadvisabletoavoidperformingwork that requiresconcentration, includingdrivingavehicle, immediatelyaftertheprocedure.Forsafetypurposes,theproceduremaybecarriedoutbeforebedtime.
TheСЕМ®-ТЕСНapparatushasbeensuccessfullydemonstratedattradeshowsinRus-siaandaroundtheworld.Thedevicehasreceivedanumberofawards,including:GoldMedalatEWEI,Sofia,Bulgaria;SilverMedalatEureka,Brussels,Belgium,2001;SilverMedalatINPEX,Pittsburgh,PA,2001;GoldMedalatVDNKh,Moscow,Russia,2003.
You must to have the consultation of the doctor before the treatment.
These methods for using the СЕМ®-ТЕСН appa-ratus have been approved by the Russian Ministry of Health. The quality assurance system under which the apparatus is manufactured is certified for conformance to European Union standards.
4
NANOTECHNOLOGY IN MEDICINE
СЕМ®-ТЕСН Patents:
1. RF Patent of Invention 2281129 “Portable pulse apparatus for electrotherapy,”dateofpriorityOctober15,2004.
2. U.S.patent6122550“Devicefortherapeuticactiononhumanorganism,”dateofpri-oritySeptember19,2000.
3. CertificateofTrademark306040for“СЕМТЕСНСЕМТЕХ,”dateofpriorityFeb-ruary07,2005.
4. CertificateofTrademark351257for“СЕМТЕСНСЕМТЕХ,”dateofpriorityMay15,2006.
5. CertificateofTrademark348805for“СЕМТЕСНСЕМТЕХ,”dateofpriorityMarch20,2007.
6. CertificateofEuropeanTrademark989300for“СЕМТЕСНСЕМТЕХ”.7. CertificateofTrademark344494for“BRRTherapy,”dateofpriorityAugust10,2006.8. Internationalapplicationforpatentofinvention“Deviceforregulatingphysiological
processesinabiologicalobject”РСТ/RU2008/000282,Patent2341851.9. Usefulmodel“Connectingandfasteningmechanism,”Patent76786,dateofpriority
May07,2008.10.DesignApplication2008500403“Apparatusforphysicaltherapy”.11.InternationalTrademarkApplicationfor“СЕМТЕСНСЕМТЕХ”.12.ApplicationforPatent2008127927“Methodforincreasingresistivityofbiologicalob-
jects”.13. ApplicationforPatent2008138337“Methodofprotectionfromthenegativeeffectsof
radiationfromcellphoneandwirelessphone”.14. UsefulModelApplication2008138260“Wirelesstelephone”.
CJSC CEM Technology and LLC Spinor are performing the following joint research projects with support from the Foundation for Supporting Small Businesses in the Field of Science and Technology:
• START-2004“Designforanewmethodofpreventionandtreatmentofinfectiousdis-easesusingcontrolledenergymaterialtechnology”.
• START-2005“Designforanewmethodofrehabilitationforpsychologicalandemo-tionaldisordersandaportablephysiopunctureapparatus for individualusewith therehabilitationmethod”.
• START-2006“Designforanewmethodofpreventionandtreatmentofinfectiousandinflammatorydiseasesoforalorgansandtissues”.
• START-2008“Groupofdevicesforprotectingindustrialmaterialsfrommicrobiologi-caldamage”.
5
List of Studied Results of the Application of EHF and BRR Therapy:
Clinical Condition Result of EHF Therapy
Neurology
Cerebralatherosclerosis Normalized cerebral circulation and lipid exchangeindicators
Headache Significant reduction in pain intensity and durationofepisodes
Vertebrobasilarinsufficiency Eliminationorsignificantreductioninheadpainanddizziness
Neurologicalsymptomsofdegenera-tivespinedisease,includingdisksyn-drome
Significant pain reduction, increased pain thresholdinlocalalgogeniczones
Thermographicpictureofdegenerativediseaseofthecervicothoracicvertebrae
NormalizedthermographicpictureafterEHFtherapy
Pediatricscoliosis Significantpainreduction,increasedtoleranceofphy-sicalexertion,increasedamplitudeofspinemotion
Exogenic-organicbraindamage(ofatraumatic, vascular, infectious/toxicandcombinednature)
Eliminationofasthenicsymptoms,moodswings,hy-peresthesia,headaches,dizziness,arterialbloodpres-surefluctuations,nighttimesleeprestoration
Mono-andpolyneuropathy Painreduction,increasedspeedofnerveimpulsecon-duction
Vegetativedisorders, includingvege-tativecrises(panicattacks)
Normalizedvegetativecondition,reductionorelimi-nation of headaches, improved hemodynamics basedonrheography
6
Clinical Condition Result of EHF TherapyPost-traumaticandstressdisorders–treatmentandprevention
Reductionoreliminationof irritability,mood swingsandsleepdisorders;improvedmoodandworkcapacity
Infantilecerebralpalsy Reducedmuscletone,increasedmobilitylevel
Epilepsy,includingdrug-resistant Reductioninthenumberofseizuresandpositivedy-namicinEEGpicture
Pulmonology
Thermographicpictureofleft-sidepneumonia
NormalizedthermographicpictureafterEHFtherapy
Pneumonia Increasedeffectivenessoftreatment,reduceddurationoftreatment,preventionoflingeringillness
Chronicnonobstructivebronchitis Anti-inflammatoryeffect
Chronicobstructivebronchitis Reliefofbroncho-obstructivesyndrome
Sarcoidosisofthelungsandintratho-raciclymphnodes
Normalizedx-rayand immunogrampicture,norma-lizedrespiratoryfunction,reducedfrequencyofaggra-vationandrecurrence
Bronchialasthma Reduced coughing and shortness of breath, reducedneedforinhaledbronchialspasmolytic,improvedmu-cus discharge, normalized respiratory function, im-munomodulatoryeffect
Vascular DiseasesObliterativeatherosclerosisofthear-teriesofthelowerlimb
Eliminationofpainsyndrome,reductionofintermit-tentlameness
Obliterativeendarteritis Eliminationofpainsyndrome,reductionofintermit-tentlameness
Raynaud’sdisease Improvedperipheralcirculationandmicrocirculation
Post-thromboticsyndrome Elimination of pain syndrome, faster healing of tro-phiculcers
Miscarriage Increaseddurationofthelutealphaseofthemenstrualcycle, increased levels of estradiol and progesterone,eliminationoftheneedforhormonetherapy
7
Clinical Condition Result of EHF TherapyPostabortalcomplications Immunomodulatoryeffect,reductionofinflammatory
complications
Chronic inflammation of the fallo-piantubes,includingimpairedrepro-ductivefunction
Pain-relievingeffect,softeningofadhesivestructures,restoredreproductivefunction
Arthropathy
Degenerative and dystrophic ar-thropathy (deformative osteoarthri-tis,psoriaticosteoarthropathy)
Anti-inflammatory effect, increased muscle strength,range of motion in affected joint and tolerance ofphysicalexertion
Thermographicpictureofrightkneearthritis
ImprovedthermographicpicturewithEHFtherapy
Hemarthrosisandhemophilicjoints Pain-relievingeffect,normalizedhemostasis
Rheumatoidarthritis Significantreductionofpainandmorning jointstiff-ness,immunomodulatoryeffect
Surgical Pathology
8
Clinical Condition Result of EHF TherapyTraumatic and post-operative dam-age to skin, soft tissueandbone tis-sue, including complications due toinfectionandslowhealing
Shortening of all phases of the wound process, anti-inflammatory effect, promotion of regeneration,includingofbone tissue,preventionof infection, sig-nificantpain-relievingeffect,reduceddosagesofpain-relievingmedications
Burns Pain-relievingeffect,fastgenerationofgranulationtis-sueandepithelialization
Post-traumaticosteomyelitis Reduceddurationoftheexudativephaseofinflamma-tionandstimulationofregenerativeprocesses
Post-traumaticstiffness Pain-relieving effect, normalization of microcircula-tion and trophic disturbances, restoration of normalrangeofmotion
Acutecholeocystitis Anti-inflammatoryeffect
Acutepancreatitis Reduceddurationoftreatment,positiveeffectonim-munesystemcondition
Gastroenterology
Ulcerofthestomachandduodenum,including bleeding complications,perforationorpenetration
Reduceddurationofepithelializationofulcerarea,re-ducedfrequencyofrecurrence
Functionalincompetenceofbilepas-sages
Fasterandmoreeffectivereliefofpainanddyspepsia,reducedsymptomsofbileinspissationsandcrystalliza-tion,normalizedgallbladdercontraction
Chronic gastroduodenitis, includinginfectionbyHelicobacterpilori
Fasterandmoreeffectivereliefofpainanddyspepsia
Chronicpancreatitis Effectivepainrelief,restoredpancreasfunction
Dermatology
9
Clinical Condition Result of EHF TherapyPsoriasis Anti-inflammatoryandregenerativeeffect,resorption
ofinfiltration,reduceddurationoftreatment,reducedfrequencyofrecurrence
Trophiculcers Anti-inflammatory, analgesic and regenerative effect,reduceddurationoftreatment,fasterepithelializationofulcerarea
Atypicaldermatitis Anti-allergiceffect,eliminationofitching
Microbialeczema Fasterhealing
Acne Fasterhealing
Neurodermatitis Reducedskinitching
Vitiligo Restoredpigmentation
Herpes Significantanalgesicandanti-inflammatoryeffects
Syphilis Immunomodulatory effect, faster return of negativeserologicalresponses
Infectious and Parasitic Diseases
Chronicopisthorchiasis Improved gallbladder contraction, disappearanceofOpisthorchiseggsinbile
Tuberculosis of the lungs, includingwithChlamydiaormycoplasmal in-fections
Stabilization over the course of tuberculosis of thelungs,reducedfrequencyofpost-operativecomplica-tions,fasterresorptionofinfiltration,abacillationandclosingofdecaycavities
Tick-borne encephalitis and tick-borneborreliosis
Increasedmobility,reducedintensityofheadachesandarthralgia,normalizedsleep,reduceddurationoffeverandasthenia,increasedantibodytiter
Viralhepatitis Fasterhealing
10
Clinical Condition Result of EHF Therapy
Thermographicpictureofacuterhinitis
NormalizedthermographicpictureafterEHFtherapy
Acute respiratory viral infections —preventionandtreatment
Ratesofinfectioncutinhalf,mildersymptomsduringillness,reduceddurationofillness,absenceofcompli-cations
Cardiology
Coronary heart disease: exertationalangina, unstable angina, myocardialinfarction,arrythmia
Significantantianginaleffect,reducednumberofan-ginaattacks,episodesofpainlessmyocardialischemiaandarrythmia,improveddiastolicfunctionoftheleftventricle, reduced dosage of nitroglycerine, norma-lizedantithrombinIIIactivityanderythrocytedefor-mation
Arterial hypertension, including hy-pertoniccrises
Hypotensive effect, reduced peripheral resistance,improved cerebral circulation, normalized catechol-amineexcretion
Non-coronary myocardial damage(mitralvalveprolapse,cardiomyopa-thy,myocarditis)
Reduced frequency of cardialgia, normalized hemo-stasisindicators,improvedqualityoflife
Eye ConditionsDiabeticretinopathy Improved electro-oculogram indicators, elimination
ofunpleasantsensationsintheeye
Inflammatoryeyediseases Eliminationofitching,antiallergiceffect
11
Clinical Condition Result of EHF Therapy
Degenerative diseases of the retinaandopticnerve
Improved vision sharpness, improved field of vision,improvedmicrocirculation
Oral Medicine
Adentiaanduseofprosthodontics Significantanti-inflammatoryeffect
Gingivitis Significantanti-inflammatoryeffect
Periodontaldisease Significant anti-inflammatory effect, stimulated re-generation,normalizedlocalcirculationinperiodon-taldisease
Thermographicpictureofsubmaxillarylymphadenopathy
Improvedthermographicpic-turewithEHFtherapy
Submaxillarylymphnodeaftertoothextraction
Significantanti-inflammatoryeffect
Andrology
Andropausedisturbances Increasedsexdrive,improvedsexualfunction
Benignprostatichyperplasia Increasedsexdrive,improvedsexualfunction
Chronicprostatitis Reliefofpainanddysuricsymptoms,improvedsexualfunction
Secretoryandtoxicinfertility Stimulationofspermatogenesis
Endocrinology
Grave’sdisease Reducedsizeofthyroid,changeinitstexture
12
Clinical Condition Result of EHF Therapy
Nodulargoiter Eliminationorreductioninthesizeofsolitarynodes
Diabetes and its complications (mi-cro- and macroangiopathy, hepato-sis,cataracts,nephropathy)
Regression of complications, stabilization of diseasecourse,reducedneedforinsulin
Liver Disease
Cirrhosis Normalizedbiochemicalindicatorsandliversizeandstructure
Chronichepatitis Normalizedbiochemicalindicatorsandliversizeandstructure
Hepatosis Normalizedbiochemicalindicatorsandliversizeandstructure
Toxicliverdamage Normalizedbiochemicalindicatorsandliversizeandstructure
Chemical Dependency
Chronicalcoholism Reducedpsychologicalstrain,anxiety,desireforalco-hol
Substanceabuse Positiveeffectonpsychological,emotionalandsoma-ticaspects
Oncology
Malignant neoplasms (including co-lonandrectalcancer,skinmelanoma,stomach cancer, mammary tumors,lung cancer, ovarian cancer, canceroftheENTorgans)
Reduction of the number and degree of polychemo-therapycomplications, reducing the frequencyof re-currenceandmetastasis,pain-relievingeffect
Beningovariantumors Normalizationofsexhormonesecretionandimmunecondition
Uterinefibroids Reductionoffibroidsize
Lymphomas (lymphogranulomatosisandnon-Hodgkinlymphomas)
Activationofbody’santioxidantdefenses,suppressionof free radicaloxidationandnormalizationofproin-flammatorycytokinelevels
Benignmammarytumors Preventionofmalignantchange
13
NANOTECHNOLOGY IN MEDICINE*DatatakenfromguidelinesapprovedbytheRussianMinistryofHealthandclini-
calstudiesperformedandanalyzedduringtheprocessofcertifyingtheСЕМ®-ТЕСНapparatusincountriesoftheEuropeanUnion.Thestudiesdescribecompletedpro-spectivecontrolledstudiesofEHFtherapyforvariousconditionsperformedaccordingto the criteria of evidence based medicine. Control groups were given standard treatment.TreatmentoftheprimarygroupsofpatientsincludedEHFtherapy.
CompleteinformationonclinicalstudiescarriedoutusingtheСЕМ®-ТЕСНapparatuscanbefoundatwww.spinor.ru.
14
NANOTECHNOLOGY IN MEDICINE
EHF Therapy Offers the Following Solutions in Oncology:
1. Preparecancerpatientswiththemostcommonlocalizationsforthestagesofcom-binedtherapy(preparingorgansandsystemsforsurgicalintervention,radiationdam-ageandaggressivedrugregimens).
2. Treatassociatedconditionsandpreventcomplications.3. Preventandtreatcomplicationsfollowingspecializedtreatmentmethods.4. Treatparaneoplasticsyndrome.5. Improveresultsofothertreatmentmethods.6. Palliativecareforterminalpatients.7. Systemiccorrectionofenvironmentalandpre-cancerouspathology.8. Preventprogressofneoplasticprocessaftercombinedtherapy.
Proven Mechanisms of Action for EHF and BRR therapy:
• Normalizationoflipidexchange(reducedconcentrationofatherogenicfractionsandincreasedhigh-densitylipoproteincontent)(Kuz’menko,1998).
• Normalizationofthebalanceofcoagulantandanti-coagulantfactors(normalizationofantithrombinIIIlevels,fibrinolyticpotentialandthrombocytichemostasis)(Lopa-tinaN.A.etal.,2003;Bukatko,V.N.2003).
• Normalization of the balance of pro- and anti-oxidant systems (Tumanyants Ye. I.,TemuryantsN.A.,1997).
• Promotionofcellregeneration(enhancedproliferationoffibroblasts)(PolyakovaA.G.etal.,1999).
• Promotionofhemogenesisinredbonemarrow(LebedevaN.N.,KotrovskayaT.I.,2002).• Normalizationofbloodflowproperties(reductionofbloodviscosity,increasederyth-
rocyteelasticity)(ParshinaS.S.,etal.,2003).• Normalizationofimmunesystemfunctioning(normalizationofthenumberofТand
В-lymphocytesandA,GandMimmunoglobulins,normalizationofthefunctioningofneutrophils,restorationofthefunctioningofВ-lymphocytesandleukocytephago-cyticactivity)(Shliapaketal.,1996;Bakaliuketal.,1998;Kuz’menko,1998;JinZ.,LinM.,XiaJ.,ZhuangJ.,YangR.,LiX.,etal.,2001;BriskinB.C.andetal,2003;BukatkoB.N.,2003).
• Restoration of the ability of mononuclear phagocytes to secrete interferon gamma,whichcanreduceincidencesofcancerinriskgrouppatients(SitkoS.P.etal.,1993).
15
NANOTECHNOLOGY IN MEDICINE• Anti-inflammatory effect based partly on stimulation of the functioning
ofphagocytesandregulationofthedegranulationofmastcells(GapeyevA.B.,ChemerisN.K.,2007).
• Normalization of the secretion of catecholamines and sex hormones (Tsa-revА.А.,KudinovaМ.А.,1997;ZaporozhanV.N.etal.,1997).
• Impactontheendogenousopioidsystem(Radzievskyetal.,2001),activationofthean-tinociceptivesystem(KirovaB.V.,2000).
• Normalizationofbrainelectricalactivity(stabilizedalpha-rhythm,restorationofini-tially disrupted interzonal and interhemispheric relations of the key EEG rhythms)(Tyshkevichetal.,1998;GubarecM.Y.,1989;StolbikovA.E.andetal,1991).
• Normalizationofvegetativeregulation,stabilizationofthebalancebetweenthesympa-theticandparasympatheticbranchesofthevegetativenervoussystem(DikkeG.B.,1999).
• Antistressoractivity—inhibitionofexcessactivityinthesympathoadrenalsystemandactivationofthestress-limitingsystems(ChuyanYe.N.,TemuryantsN.А.,2005).
• Inhibitionoffluvirusreplicationincells,anti-viraleffect(PodchernyaevaR.Ya.etal.,2004).
• Cytoprotectiveeffectonredbonemarrowandliverinpatientsreceivingpolychemo-therapy(KarevaN.P.etal.,2006).
• Changetothestructuralanddynamiccharacteristicsofcellmembranes(SeminaI.G.etal.,2007).
• Slowingofagingprocessesforskin,liverandthecentralnervoussystem(RodshtatI.V.,2007).
• Normalization of vascular tone and promotion of microcirculation, normalizationoftheresponsivenessofvascularendothelium(normalizedrheogramandrheoenceph-alogramindicators)(ParshinaS.S.etal.,2003;DikkeG.B.,1999;AfanasyevaТ.N.,PetrovaV.D.,1995;TsarevА.А.,KudinovaМ.А.,1997).
• Increased overall resistance (immunity) to many different negative factors (Tuman-yantsYe.I.,TemuryantsN.А.,1997).
Thermographicpictureofsecondarythymic-dependent
immunodeficiency
NormalizedthermographicpictureafterEHFtherapy
16
NANOTECHNOLOGY IN MEDICINE
Notes